Providing market research reports, industry analysis, company profiles and country reports for strategic planning, competitive intelligence, marketing and business research.
Search for Market Research Reports:    

Global Intravenous (IV) Iron Drugs Market: Potential Opportunities

Published by: Koncept Analytics

Published: Feb. 1, 2009 - 32 Pages


Table of Contents


1. Iron Deficiency Anemia: An Overview

1.1 Introduction - Iron Deficiency Anemia

1.2 Prevalence of iron deficiency anemia

2. Chronic Kidney Disease (CKD) and IV Iron Products

2.1 Prevalence of CKD

2.2 CKD associated anemia

2.3 Prevalence of CKD associated anemia

2.4 CKD associated anemia - Therapies

2.4.1 Oral Iron Repletion Therapy
2.4.2 Intravenous Iron Infusion Therapy

2.5 Applications of IV iron products in therapeutic areas
3. Global Market for Iron-Based Medicines

4. Intravenous Iron (IV) Drugs: Global Market

5. US Intravenous Iron (IV) Drugs Market

6. Growth Drivers

7. Market Opportunities

8. Competitive Landscape

9. Leading IV Drugs Companies

9.1 Galenica Ltd. (Venofer and Ferinject)

9.1.1 Company Description
9.1.2 Major Products

9.1.3 Business Strategies

9.2 Watson Pharma (Ferrlecit and InFed)
9.2.1 Company Description
9.2.2 Major Products

9.2.3 Business Strategies

10. Market Forecast

Tables and Figures

Table 1.1: Stages of chronic kidney disease

Figure 2.1: Prevalence of CKD in the US Population: 1996-2020

Figure 2.1: US CKD: Patients undergoing Dialysis & receiving Iron Treatment

Figure 3.1: Global Market of Iron Products: 2003-2007

Figure 3.2: Market Share of Oral and IV Iron Drugs: 2007

Figure 4.1: Global IV Iron Market: 2006 & 2007 (Forecast 2008-2010)

Figure 4.2: Global IV Iron Sales Break-up (In & outside dialysis CKD): 2006 & 2007 (Forecast 2008-2010)

Figure 4.3: Global IV Iron Sales by Geography: 2007

Figure 5.1: US CKD Patient Profile

Figure 5.2: US IV Iron Market: 2006 & 2007 (Forecast 2008-2010)

Figure 5.3: US Intravenous Iron Market - Share by Brands: 2007

Figure 6.1: Number of dialysis patients worldwide - Trends (2004-2015)

Figure 6.2: Prevalence of Diabetes in Five Major Countries: 2000 & 2010

Figure 6.3: Incidence of ESRD by year (per million population): Major Countries

Figure 6.4: Prevalence of ESRD by year (per million population): Major Countries

Figure 7.1: IV Market Potential - Major therapeutic areas

Figure 8.1: Global Iron Drugs Supplement Market Share: 2006

Figure 8.2: Global Market Share of leading IV iron drugs players: 2003-07

Figure 8.3: Global Market Share of Parenteral IV Drugs: 2007

Figure 10.1: Global IV Iron Market Forecast: 2008-2010

Figure 10.2: CKD Dialysis & Non Dialysis: Patients receiving Iron Treatment

Abstract

Iron deficiency anemia or IDA is among one of the top ten most important public health issues, according to the World Health Organization. With approximately one-third of the current global population facing the problem of iron deficiency, more and more people are likely to suffer from a lack of iron in their diet in the near future due to changes in eating habits and rising life expectancy.

Currently, iron supplements used in the context of IDA account for the majority share of the iron-based medicines but this is likely to change with the growing utility of intravenous iron (IV) drugs. Earlier, the IV iron market was mainly achieved in the hemodialysis (HD) setting, but IV iron is likely to be used more in many other therapeutic areas which are highly under-penetrated.

One of the major attractiveness of IV iron especially in regions outside the United States is its pricing and growing number of CKD population. Generally the pricing of IV irons outside the U.S. is lower and the iron market in countries like China is underdeveloped, but growing rapidly, with tremendous potential.

Venofer from Galenica Limited has emerged as the undisputed leader in the IV iron drugs market overtaking the market share of Watson’s InFed and Ferrlecit. Still the whole IV iron market holds immense business opportunities mainly because of increase in the number of haemodialysis patients and limitation in various iron replacement therapies and scope for innovation.

The report titled “Global Intravenous (IV) Iron Drugs Market: Potential Opportunities” analyzes the IV iron market in the context of opportunities it holds for iron drug manufacturers. The report presents statistics on the growing population of patients who are suffering from critical conditions that calls for the need of iron drugs. Further, it analyzes the factors that could drive the growth of IV drugs market in the future. It also profiles the two major manufacturers of iron drugs - Galenica and Watson Pharma. Further, the future growth of the IV iron drugs market has been analyzed in the report.

Get Full Details About This Report >>
US: 800.298.5699
Int'l: +1.240.747.3093
Buy this Report
Price and Delivery Options
Search Inside Report


 

About MarketResearch.com
MarketResearch.com is an online aggregator selling over 250,000 market research reports, company profiles and country profiles from over 650 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.

 

© MarketResearch.com 2009